Hepatology Market 2025 to 2034
Hepatology Market 2025 to 2034
Hepatology Market (By Treatment Type: Antiviral Drugs, Vaccines, Immunosuppressants, Targeted Therapy, Chemotherapy, Corticosteroids, Immunoglobulins; By Disease Type: Hepatitis, Liver Cancer, Genetic Disorders, Autoimmune Diseases, Non-Alcoholic Fatty Liver Diseases, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 18.26 Bn
Forecast Year, 2035
USD 55.78
CAGR, 2025 - 2035
11.81%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global hepatology market, valued at USD 18.26 billion in 2025, is projected to reach USD 55.78 billion by 2035, expanding at a robust CAGR of 11.81%, driven by rising liver disease prevalence, advanced therapies, and increasing healthcare awareness.
Hepatology Market Size Analysis
Hepatology Market Size By Treatment Type 2025 to 2034 (USD Billion)
| Treatment Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Antiviral Drugs | 0.65 | 0.73 | 0.83 | 0.92 | 1.02 | 1.15 | 1.29 | 1.43 | 1.61 | 1.78 |
| Vaccines | 1.31 | 1.46 | 1.63 | 1.82 | 2.05 | 2.29 | 2.54 | 2.86 | 3.19 | 3.58 |
| Immunosuppressants | 1.96 | 2.19 | 2.45 | 2.74 | 3.06 | 3.41 | 3.84 | 4.27 | 4.77 | 5.34 |
| Targeted Therapy | 2.61 | 2.92 | 3.26 | 3.64 | 4.09 | 4.57 | 5.10 | 5.69 | 6.36 | 7.13 |
| Chemotherapy | 3.26 | 3.64 | 4.08 | 4.56 | 5.09 | 5.69 | 6.36 | 7.13 | 7.97 | 8.90 |
| Corticosteroids | 3.91 | 4.37 | 4.89 | 5.47 | 6.11 | 6.84 | 7.63 | 8.55 | 9.54 | 10.68 |
| Immunoglobulins | 4.56 | 5.11 | 5.70 | 6.37 | 7.13 | 7.96 | 8.91 | 9.96 | 11.15 | 12.46 |
Hepatology Market Size By Disease Type 2025 to 2034 (USD Billion)
| Disease Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis | 0.87 | 0.97 | 1.09 | 1.22 | 1.37 | 1.52 | 1.71 | 1.90 | 2.12 | 2.39 |
| Liver Cancer | 1.74 | 1.95 | 2.18 | 2.43 | 2.73 | 3.06 | 3.39 | 3.80 | 4.26 | 4.74 |
| Genetic Disorders | 2.61 | 2.92 | 3.27 | 3.65 | 4.08 | 4.55 | 5.10 | 5.71 | 6.38 | 7.14 |
| Autoimmune Diseases | 3.49 | 3.89 | 4.34 | 4.86 | 5.43 | 6.07 | 6.81 | 7.61 | 8.50 | 9.50 |
| Non- Alcoholic Fatty Liver Diseases | 4.35 | 4.85 | 5.44 | 6.07 | 6.79 | 7.58 | 8.48 | 9.48 | 10.60 | 11.88 |
| Others | 5.21 | 5.83 | 6.52 | 7.29 | 8.16 | 9.12 | 10.19 | 11.39 | 12.73 | 14.23 |
Hepatology Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.83 | 2.04 | 2.30 | 2.57 | 2.85 | 3.19 | 3.57 | 4.05 | 4.53 | 5.02 |
| LAMEA | 3.66 | 4.09 | 4.56 | 5.11 | 5.73 | 6.41 | 7.18 | 7.99 | 8.95 | 9.95 |
| Europe | 5.48 | 6.11 | 6.86 | 7.66 | 8.56 | 9.55 | 10.68 | 11.92 | 13.35 | 14.97 |
| Asia-Pacific | 7.30 | 8.18 | 9.11 | 10.18 | 11.40 | 12.76 | 14.25 | 15.93 | 17.77 | 19.93 |
Hepatology Market Size to Hit USD 55.78 Billion by 2035
The global hepatology market size accounted for USD 18.26 billion in 2025 and is predicted to touch around USD 55.78 billion by 2035 with a growing at a CAGR of 11.81%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
